Key facts
- This page summarizes John D. Halpern's Form 4 filing for Eterna Therapeutics Inc. (ERNA).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 05 Dec 2022, 17:05.
John D. Halpern - 02 Dec 2022 Form 4 Insider Report for Eterna Therapeutics Inc. (ERNA)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- ERNA
- Reported as of
- 02 Dec 2022
- Net transaction value
- +$1,185,798
- SEC form
- 4
- Accepted by SEC
- 05 Dec 2022, 17:05:45 UTC
- Prior SEC filing
- 19 May 2021
- Next SEC filing
- 08 Jan 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ John D. Halpern
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
John D. Halpern filed Form 4 for Eterna Therapeutics Inc. (ERNA) on 05 Dec 2022.
Change
- Previous filing in this sequence was filed on 19 May 2021.
- Current net transaction value: +$1,185,798.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ERNA
transaction
Common Stock
Purchase
- Transaction value
- $1,101,818
- Shares
- +335,920
- Change %
- +292%
- Price
- $3.28
- Shares after
- 450,961
- Date
- 02 Dec 2022
- Ownership
- As trustee of family trust
- Footnotes
- F1, F3, F4
ERNA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 205
- Date
- 02 Dec 2022
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ERNA
transaction
Derivative
Warrants (Right to Purchase)
Purchase
- Transaction value
- $83,980
- Shares
- +671,840
- Change %
- Price
- $0.1250*
- Shares after
- 671,840
- Date
- 02 Dec 2022
- Ownership
- As trustee of family trust
- Underlying class
- Common Stock
- Underlying amount
- 671,840
- Exercise price
- $3.28
- Footnotes
- F4, F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
John D. Halpern is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 5 footnotes
Footnote F1
Reflects a 1-for-20 reverse stock split effective October 17, 2022.
Footnote F2
Held by John D. Halpern
Footnote F3
Each share was purchased as part of a unit consisting of one share and two warrants, for a total purchase price of $3.53 per unit.
Footnote F4
The reporting persons disclaim beneficial ownership of these shares except to the extent of their pecuniary interest therein, if any.
Footnote F5
The exercisability of the Warrants is subject to a 9.99% beneficial ownership limitation.